Boston Scientific Corp Insider Trading
Every director, officer and 10% holder of Boston Scientific Corp has to report each trade in its stock within two business days of making it. This is those filings.
BSX on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| Susan E MoranoDirector2026-08-252K shat $49.22 | Purchase | $100.4K |
| David C HabigerDirector2026-08-052.1K shat $47.59 | Purchase | $99.9K |
| David C HabigerDirector2026-08-04140 shat $48.59 | Purchase | $6.8K |
| David C HabigerDirector2026-08-031K shat $48.07 | Purchase | $50.1K |
| Michael F MahoneyChairman, President & CEO2026-08-03186.2K shat $48.33 | Purchase | $9M |
| Edward J LudwigDirector2026-07-315K shat $45.48 | Purchase | $227.4K |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on BSX
Follow Boston Scientific Corp (BSX) by email
New trades in Boston Scientific Corp (BSX) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.